You are here

  • Home
  • Archive
  • Volume 23, Issue 2
  • Assessing the validity of surrogate endpoints in the context of a controversy about the measurement of effectiveness of hepatitis C virus treatment

Article Text

Article menu
Download PDFPDF
Research methods and reporting
Assessing the validity of surrogate endpoints in the context of a controversy about the measurement of effectiveness of hepatitis C virus treatment

https://doi.org/10.1136/bmjebm-2017-110852

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    PDF extract preview

    You do not have access to the full text of this article, the first page of the PDF of this article appears above.

    Footnotes

    • Contributors CCD conceived the idea and drafted the manuscript. All authors contributed to critical discussions of the ideas, commented on versions of the manuscript and approved the final submission.

    • Funding Department of Health, Australian Government, National Health and Medical Research Council (APP1123733).

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; externally peer reviewed.